TY - T1的治疗效果没有定义ntuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00170-2018 VL - 51 IS - 3 SP - 1800170 AU - van Ingen, Jakko AU - Aksamit, Timothy AU - Andrejak, Claire AU - Böttger, Erik C. AU - Cambau, Emmanuelle AU - Daley, Charles L. AU - Griffith, David E. AU - Guglielmetti, Lorenzo AU - Holland, Steven M. AU - Huitt, Gwen A. AU - Koh, Won-Jung AU - Lange, Christoph AU - Leitman, Philip AU - Marras, Theodore K. AU - Morimoto, Kozo AU - Olivier, Kenneth N. AU - Santin, Miguel AU - Stout, Jason E. AU - Thomson, Rachel AU - Tortoli, Enrico AU - Wallace, Richard J. AU - Winthrop, Kevin L. AU - Wagner, Dirk A2 - , Y1 - 2018/03/01 UR - //www.qdcxjkg.com/content/51/3/1800170.abstract N2 - Nontuberculous mycobacterial pulmonary diseases (NTM-PD) are increasingly recognised as opportunistic infections of humans. These chronic pulmonary infections have two main presentations. The first is a fibro-cavitary disease, that occurs in patients with pre-existing pulmonary diseases, such as chronic obstructive pulmonary disease, bronchiectasis, previous tuberculosis or other structural lung disease. The second presentation is a nodular-bronchiectatic disease of primarily the lingula and middle lobe that tends to affect a middle-aged and elderly female population [1].Improving treatment outcome reporting in NTM disease: NTM-NET (@ntmnet) consensus statement on treatment outcome definitions http://ow.ly/c6IC30iwLM4The authors wish to thank the American Thoracic Society, European Respiratory Society, Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases for organising the two meetings during which the process leading to this statement was initiated. These organisations do not officially endorse this NTM-NET consensus statement. ER -